drugset / Trial / NCT00394160

Safety and Pk Study in 1- to 3- Month-Old Children With Bronchiolitis (0476-297)

NCT00394160

Phase 2 Completed 12 enrolled Organon and Co
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to look at the preliminary safety profile of an investigational drug in children 1 to \< 3 months of age with bronchiolitis.

Timeline

Start
2004-12
Primary completion
2005-10
Completion
2005-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Montelukast Other / unclassified Oral

Indications